PubMed

The fate of [U-(13)C]palmitate extracted by skeletal muscle in subjects with type 2 diabetes and control subjects.

Blaak EE, Wagenmakers AJ.

Diabetes. 2002 Mar;51(3):784-9.PMID: 11872680 [PubMed - indexed for MEDLINE]Related articlesFree article

Plasma FFA utilization and fatty acid-binding protein content are diminished in type 2 diabetic muscle.

Blaak EE, Wagenmakers AJ, Glatz JF, Wolffenbuttel BH, Kemerink GJ, Langenberg CJ, Heidendal GA, Saris WH.

Am J Physiol Endocrinol Metab. 2000 Jul;279(1):E146-54.PMID: 10893334 [PubMed - indexed for MEDLINE]Related articlesFree article

Heterogeneity in limb fatty acid kinetics in type 2 diabetes.

Sacchetti M, Olsen DB, Saltin B, van Hall G.

Diabetologia. 2005 May;48(5):938-45. Epub 2005 Apr 14.PMID: 15830181 [PubMed - indexed for MEDLINE]Related articles

Dysregulation of muscle fatty acid metabolism in type 2 diabetes is independent of malonyl-CoA.

Bell JA, Volpi E, Fujita S, Cadenas JG, Rasmussen BB.

Diabetologia. 2006 Sep;49(9):2144-52. Epub 2006 Jul 26.PMID: 16868746 [PubMed - indexed for MEDLINE]Related articles

Beta-adrenergic stimulation of energy expenditure and forearm skeletal muscle metabolism in lean and obese men.

Blaak EE, Van Baak MA, Kemerink GJ, Pakbiers MT, Heidendal GA, Saris WH.

Am J Physiol. 1994 Aug;267(2 Pt 1):E306-15.PMID: 7915493 [PubMed - indexed for MEDLINE]Related articles

Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects.

Wilmsen HM, Ciaraldi TP, Carter L, Reehman N, Mudaliar SR, Henry RR.

Am J Physiol Endocrinol Metab. 2003 Aug;285(2):E354-62. Epub 2003 Apr 15.PMID: 12700163 [PubMed - indexed for MEDLINE]Related articlesFree article

Beta-adrenergically stimulated fat oxidation is diminished in middle-aged compared to young subjects.

Blaak EE, van Baak MA, Saris WH.

J Clin Endocrinol Metab. 1999 Oct;84(10):3764-9.PMID: 10523027 [PubMed - indexed for MEDLINE]Related articlesFree article

Differential utilization of saturated palmitate and unsaturated oleate: evidence from cultured myotubes.

Gaster M, Rustan AC, Beck-Nielsen H.

Diabetes. 2005 Mar;54(3):648-56.PMID: 15734839 [PubMed - indexed for MEDLINE]Related articlesFree article

Substrate utilization in non-obese Type II diabetic patients at rest and during exercise.

Borghouts LB, Wagenmakers AJ, Goyens PL, Keizer HA.

Clin Sci (Lond). 2002 Dec;103(6):559-66.PMID: 12444908 [PubMed - indexed for MEDLINE]Related articles

Substrate source utilization during moderate intensity exercise with glucose ingestion in Type 1 diabetic patients.

Robitaille M, Dubé MC, Weisnagel SJ, Prud'homme D, Massicotte D, Péronnet F, Lavoie C.

J Appl Physiol. 2007 Jul;103(1):119-24. Epub 2007 Apr 12.PMID: 17431081 [PubMed - indexed for MEDLINE]Related articlesFree article

Reduced insulin-mediated citrate synthase activity in cultured skeletal muscle cells from patients with type 2 diabetes: evidence for an intrinsic oxidative enzyme defect.

Ortenblad N, Mogensen M, Petersen I, Højlund K, Levin K, Sahlin K, Beck-Nielsen H, Gaster M.

Biochim Biophys Acta. 2005 Jun 30;1741(1-2):206-14. Epub 2005 Apr 22.PMID: 15894466 [PubMed - indexed for MEDLINE]Related articles

Reduced lipid oxidation in skeletal muscle from type 2 diabetic subjects may be of genetic origin: evidence from cultured myotubes.

Gaster M, Rustan AC, Aas V, Beck-Nielsen H.

Diabetes. 2004 Mar;53(3):542-8.PMID: 14988236 [PubMed - indexed for MEDLINE]Related articlesFree article

beta-Adrenergic stimulation of skeletal muscle metabolism in relation to weight reduction in obese men.

Blaak EE, Van Baak MA, Kemerink GJ, Pakbiers MT, Heidendal GA, Saris WH.

Am J Physiol. 1994 Aug;267(2 Pt 1):E316-22.PMID: 7915494 [PubMed - indexed for MEDLINE]Related articles

Weight reduction and the impaired plasma-derived free fatty acid oxidation in type 2 diabetic subjects.

Blaak EE, Wolffenbuttel BH, Saris WH, Pelsers MM, Wagenmakers AJ.

J Clin Endocrinol Metab. 2001 Apr;86(4):1638-44.PMID: 11297597 [PubMed - indexed for MEDLINE]Related articlesFree article

Skeletal muscle interleukin-6 and tumor necrosis factor-alpha release in healthy subjects and patients with type 2 diabetes at rest and during exercise.

Febbraio MA, Steensberg A, Starkie RL, McConell GK, Kingwell BA.

Metabolism. 2003 Jul;52(7):939-44.PMID: 12870175 [PubMed - indexed for MEDLINE]Related articles

Plasma free Fatty Acid uptake and oxidation are already diminished in subjects at high risk for developing type 2 diabetes.

Mensink M, Blaak EE, van Baak MA, Wagenmakers AJ, Saris WH.

Diabetes. 2001 Nov;50(11):2548-54.PMID: 11679433 [PubMed - indexed for MEDLINE]Related articlesFree article

Abnormal renal, hepatic, and muscle glucose metabolism following glucose ingestion in type 2 diabetes.

Meyer C, Woerle HJ, Dostou JM, Welle SL, Gerich JE.

Am J Physiol Endocrinol Metab. 2004 Dec;287(6):E1049-56. Epub 2004 Aug 10.PMID: 15304374 [PubMed - indexed for MEDLINE]Related articlesFree article

Impaired fatty acid metabolism in type 2 diabetic skeletal muscle cells is reversed by PPARgamma agonists.

Cha BS, Ciaraldi TP, Park KS, Carter L, Mudaliar SR, Henry RR.

Am J Physiol Endocrinol Metab. 2005 Jul;289(1):E151-9. Epub 2005 Feb 22.PMID: 15727952 [PubMed - indexed for MEDLINE]Related articlesFree article

Substrate utilization and thermogenic responses to beta-adrenergic stimulation in obese subjects with NIDDM.

Blaak EE, Saris WH, Wolffenbuttel BH.

Int J Obes Relat Metab Disord. 1999 Apr;23(4):411-8.PMID: 10340820 [PubMed - indexed for MEDLINE]Related articles

Human skeletal muscle fatty acid and glycerol metabolism during rest, exercise and recovery.

van Hall G, Sacchetti M, Rådegran G, Saltin B.

J Physiol. 2002 Sep 15;543(Pt 3):1047-58.PMID: 12231658 [PubMed - indexed for MEDLINE]Related articlesFree article